Daniel Javitt - 03 Jun 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
10%+ Owner
Signature
Daniel Javitt
Issuer symbol
NRXP
Transactions as of
03 Jun 2022
Transactions value $
-$303,910
Form type
4
Filing time
07 Jun 2022, 20:11:10 UTC
Previous filing
02 Nov 2021
Next filing
05 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Sale -$171K -244K -1.86% $0.70 12.9M 03 Jun 2022 by Glytech LLC F1
transaction NRXP Common Stock Sale -$76.9K -116K -0.9% $0.67 12.7M 06 Jun 2022 by Glytech LLC F1
transaction NRXP Common Stock Sale -$55.9K -86.5K -0.68% $0.65 12.7M 07 Jun 2022 by Glytech LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Glytech LLC of which the Reporting Person is the sole owner.